Skip to content

Cannabis: all studies

Page 269 of 287: studies 2,681 to 2,690 of 2,864, newest first. Back to the cannabis overview

Research

Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.

Clinical Neuropharmacology 2009 Massimiliano Aragona, Emanuela Onesti, Valentina Tomassini et al.

To study possible psychopathological symptoms and cognitive deficits, abuse induction, as well as general tolerability and effects on quality of life, fatigue and motor function in cannabis-naïve patients with multiple sclerosis (MS) treated with a free-dose cannabis plant extract (Sativex). In an 8-week, randomized, double-blind, placebo-controlled, parallel group crossover trial, 17...

Psychedelic Psychiatry: LSD from Clinic to Campus by Erica Dyck

Health and History 2009 Mathew T Martin-Iverson

Health& History 1112 2009 159 has to sort through a lot of other stuff to get it.He has some trouble keeping onmessage, often diverting tonon-related areas of psychiatric history. Then, we have to deal with his well-known opinions of the dreaded drug companies who are undoubtedly a part of the history, but could have been dealt with more objectively. I rather enjoyed his interludes into the...

Interactions between 3,4-Methylenedioxymethamphetamine and Ethanol in Humans and Rodents

Neuropsychobiology 2009 Wael M.Y. Mohamed, Sami Ben Hamida, Anne Pereira De Vasconcelos et al.

Methylenedioxymethamphetamine (MDMA, ecstasy) is a widely used recreational drug, often associated with dance parties. Users self-report euphoria, a sense of well-being and increased feelings of affiliation. In experimental animals, MDMA produces an acute, rapid release of serotonin and, to a lesser extent, dopamine and norepinephrine in the brain. It can also produce a dose-dependent,...

Evidence for selective executive function deficits in ecstasy/polydrug users.

Journal of Psychopharmacology January 2009 John E. Fisk, C Montgomery

Previous research has suggested that the separate aspects of executive functioning are differentially affected by ecstasy use. Although the inhibition process appears to be unaffected by ecstasy use, it is unclear whether this is true of heavy users under conditions of high demand. Tasks loading on the updating process have been shown to be adversely affected by ecstasy use. However, it remains...

Investigating the role of serotonin in visual orientation processing using an 'ecstasy' (MDMA)-based research model.

Neuropsychobiology 2009 Clare Dickson, Raimondo Bruno, John Brown

A growing body of evidence suggests that regular 'ecstasy' (3,4-methylenedioxymethamphetamine) use causes lasting changes to central serotonergic functioning in humans, including in the occipital lobe. Serotonin may play a role in visual orientation processing, mediated in the occipital lobe, via lateral inhibition. The tilt aftereffect is an illusion apparent following adaptation to stimuli...

Familial Predisposition for Psychiatric Disorder

Archives of General Psychiatry November 3, 2008 Mikkel Christoffer Berg B. Arendt, Preben Bo Mortensen, Raben Rosenberg et al. 77 citations

CONTEXT: Cannabis-induced psychosis is considered a distinct clinical entity in the existing psychiatric diagnostic systems. However, the validity of the diagnosis is uncertain. OBJECTIVES: To establish rate ratios of developing cannabis-induced psychosis associated with predisposition to psychosis and other psychiatric disorders in a first-degree relative and to compare them with the...

Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?

Journal of Psychopharmacology November 2008 G Bedi, J Redman

Previous research has found relationships between self-rated memory and ecstasy use, such that heavier users report worse function. These findings have been interpreted in terms of objective memory capacity. However, research on metamemory suggests that self-reported memory may be only weakly related to objective function, with demographics, mood, and memory-related beliefs and feelings also...

Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.

Current Drug Abuse Reviews November 2008 George Panagis, Styliani Vlachou, George G. Nomikos

Cannabis preparations as recreational drugs are the most widely used illicit drugs in the world. Although cannabis derivatives produce clear subjective motivational responses in humans leading to drug-seeking behavior and in a specific proportion in repeated drug use, the reinforcing/rewarding attributes of these subjective effects are difficult to define in experimental animals. This led to...

Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats.

Addiction Biology September 2008 Jenny L Wiley, Rhys L Evans, Darren B Grainger et al.

Lifelong substance abuse is often initiated during adolescence; yet, most pre-clinical research in this area has been conducted in adult animals. Substantial evidence exists that the brain development that continues throughout adolescence may result in pharmacological responses that differ in a crucial manner from those of adults. The goal of this study was to evaluate age differences in motor...

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

Psychological Medicine September 1, 2008 G. Bedi, J. Redman 68 citations

BackgroundAlthough there have been several reports linking ecstasy use with lowered cognitive function, much previous research suffers from substantial methodological limitations. The present study aimed to examine associations between ecstasy use and higher-level cognitive functions, using a larger sample size than most previous research and better controlling for a range of potential...